Institut des Maladies Emergentes et Thérapies Innovantes (iMETI)
Service des Thérapies Innovantes - Inserm U962
Commissariat à l'énergie atomique
Centre de Fontenay-aux-Roses
18, route du Panorama - BP6
92265 Fontenay aux Roses Cedex, France
 | edouard.dreuzy@gmail.com |
Edouard de Dreuzy
http://fr.linkedin.com/in/edouarddreuzy/en
---| March 2016 - Today
Genethon/INTEGRARE Blood and Immune Diseases Program
---| September 2011 – February 2016
PhD Student at CEA -- Institute of emerging diseases and innovative therapy (iMETI)
Inserm U962 - Fontenay-aux-Roses
Gene and Cell therapy Laboratory
-Effect of the insertional activation of HMGA2 by lentiviral vectors in the context of the clinical trial "LentiGlobin".
-Development of novel targeting strategies for gene therapy.
---| April 2011 – september 2011 : Research assistant Intern
GlaxoSmithKline, Stevenage (United Kingdom)
-Epigenetic target validation for immuno-inflammatory diseases.
-Hit compounds testing by cell biology assays.
---| September 2009 – February 2010 : Research assistant Intern
Genethon, Evry (France)
- Physiopathology of dysferlinopathy : Observation of membrane tears in mice skeletal muscle fibers during excentric contractions by in vivo confocal imaging with fluorescence
- Development of a cell membrane repair test to assess the functionality of dysferlin after gene therapy
- Development of a calcium imaging technique on isolated skeletal muscle fibers
http://fr.linkedin.com/in/edouarddreuzy/en
---| March 2016 - Today
Genethon/INTEGRARE Blood and Immune Diseases Program
---| September 2011 – February 2016
PhD Student at CEA -- Institute of emerging diseases and innovative therapy (iMETI)
Inserm U962 - Fontenay-aux-Roses
Gene and Cell therapy Laboratory
-Effect of the insertional activation of HMGA2 by lentiviral vectors in the context of the clinical trial "LentiGlobin".
-Development of novel targeting strategies for gene therapy.
---| April 2011 – september 2011 : Research assistant Intern
GlaxoSmithKline, Stevenage (United Kingdom)
-Epigenetic target validation for immuno-inflammatory diseases.
-Hit compounds testing by cell biology assays.
---| September 2009 – February 2010 : Research assistant Intern
Genethon, Evry (France)
- Physiopathology of dysferlinopathy : Observation of membrane tears in mice skeletal muscle fibers during excentric contractions by in vivo confocal imaging with fluorescence
- Development of a cell membrane repair test to assess the functionality of dysferlin after gene therapy
- Development of a calcium imaging technique on isolated skeletal muscle fibers
